Articles On Ark Mines (ASX:AHK)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: Another sparkling resources IPO as ASX microcaps hit cruise control
Local stocks hit cruise control heading into the Easter break, with steady gains across the ASX in a calm session. The microcap ASX Emerging Companies index rose by around 0.8%, slightly outperforming the big end of town. It followed a soli... |
Stockhead | AHK | 2 years ago |
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot... |
Stockhead | AHK | 2 years ago |
Ark Mines (ASX:AHK) extends drilling at Gunnawarra following ‘outstanding result’
Ark Mines (AHK) extends its drilling program at the Gunnawarra project in North Queensland after intersecting extensive nickel and cobalt mineralisation With 1430 metres of RC drilling completed, nickel and cobalt has been identified up to... |
themarketherald.com.au | AHK | 2 years ago |
WTC, SQ2, XRO, ALU: Why are these technology stocks in news today?
Highlights The ASX-listed technology stocks fell for the second consecutive day on Friday. Today, the S&P/ASX 200 Information Technology (ASX:XIJ) Sector was down 0.434% at 1770.100 points at 2:03 PM AEST. WiseTech Global Limited... |
Kalkine Media | AHK | 2 years ago |
Closing Bell: International Graphite climbs 97.5% in its first session, all else is dust
The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow... |
Stockhead | AHK | 2 years ago |
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve... |
Stockhead | AHK | 2 years ago |
Ark Mines (ASX:AHK) finds lateritic material in maiden drill program at Gunnawarra, QLD
Ark Mines (AHK) officially launches a maiden reverse circulation (RC) drilling program at the Gunnawarra nickel-cobalt project in North Queensland. Ark confirms that lateritic material has been encountered up to 40 metres deep in some loca... |
themarketherald.com.au | AHK | 2 years ago |
Ark Mines (ASX:AHK) poised to start drilling at Gunnawarra
Ark Mines (AHK) set to begin reverse circulation drilling at its Gunnawarra nickel-cobalt project in North Queensland The 2,000 metre program will test laterite nickel cobalt deposits, and underlying ultramafic basement rocks identified du... |
themarketherald.com.au | AHK | 2 years ago |
Closing Bell: Shazam for coughing and THIS is how the small cap index surfs the chop – up 10% in a month
ASX Emerging Companies (XEC) index has closed 1.5% on Tuesday Index now over 10% the better since February 22 Tuesday winners: ResApp (ASX:RAP), RiversGold (ASX:RGL) The ASX Emerging Companies (XEC) index is 1.5% higher in late trade.... |
Stockhead | AHK | 2 years ago |
Closing Bell: ASX flat, but volatile
ASX Emerging Companies (XEC) index has closed o.2% higher Monday Monday winners: Terramin Australia (ASX:TZN), Frontier Resources (ASX:FNT), Ardea Resources (ASX:ARL) Monday losers: Melbana Energy (ASX:MAY) The ASX Emerging Companies... |
Stockhead | AHK | 2 years ago |
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month
Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal... |
Stockhead | AHK | 2 years ago |
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX
The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby... |
Stockhead | AHK | 2 years ago |
R3D Resources (ASX:R3D) and Ark Mines (ASX:ARK) join forces in copper oxide MOU
R3D Resources (R3D) signs a deal with Ark Mines (ARK) for the purchase and processing of copper oxide Through a non-binding memorandum of understanding, Ark will provide 2375 tonnes of ore per year to form part of the copper feed for R3D’s... |
themarketherald.com.au | AHK | 2 years ago |
Hot Money Monday: Resources rule the roost in January
Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le... |
Stockhead | AHK | 2 years ago |
Hot Money Monday: Global Lithium holds top spot, now up 200% since November capital raise
Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le... |
Stockhead | AHK | 2 years ago |
Closing Bell: ASX bounces back as US markets prepare for the inflation genie
ASX investors got back in the risk saddle on Wednesday, with steady gains across the large cap indexes and a 1.7% jump for the microcap Emerging Companies index. The catalyst appeared to be comments from US Fed Chair Jerome Powell overnight... |
Stockhead | AHK | 2 years ago |
ASX Update: ASX bounces back after two days of losses
The ASX has jumped out of the blocks this morning, as expected, after two consecutive days of losses. The S&P/ASX 200 Index has risen 35.8 points, or 0.48 per cent, to 7,425.90. What’s driving the market The Nasdaq continued... |
themarketherald.com.au | AHK | 2 years ago |
Top 10 at 10: These stocks are on top of the world
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov... |
Stockhead | AHK | 2 years ago |
December ASX Winners Column: Health and telco stocks plus recapitalised resources companies won the month
ASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 being the second best of the year. Ultimately, the market finished 2021 13% higher than it started. Patience pays off, unless you got in at the... |
Stockhead | AHK | 2 years ago |
Closing Bell: ASX completes its strongest week in nearly 2 months
The ASX closed for the Christmas break on a high, with its biggest weekly gain since the first week of November. Despite today being a shortened trading day the ASX gained 0.50%, taking its weekly gain to 1.66%. All sectors enjoyed gains bu... |
Stockhead | AHK | 2 years ago |
10 at 10: These ASX stocks are gifts that keep on giving this morning
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov... |
Stockhead | AHK | 2 years ago |
Market Highlights and 5 ASX Small Caps to watch on Friday
Wall Street gains for third consecutive day US stocks staged a pre-Christmas rally as omicron fears eased, with the S&P 500 nearing its record high. All three major US stockmarket indexes rose overnight – the S&P 500 by 0.62%, Dow J... |
Stockhead | AHK | 2 years ago |
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %... |
Stockhead | AHK | 2 years ago |
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont... |
Stockhead | AHK | 2 years ago |
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M... |
Stockhead | AHK | 2 years ago |
Ark Mines (ASX:AHK): A ground floor investment opportunity in the mineral exploration sector
Ark Mines (AHK) is a ground floor opportunity to invest in a unique, multi-commodity initial public offering (IPO) The company owns three exploration assets in Northern Queensland prospective for a range of materials including copper, iron... |
themarketherald.com.au | AHK | 2 years ago |
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat... |
Stockhead | AHK | 2 years ago |
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N... |
Stockhead | AHK | 2 years ago |
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du... |
Stockhead | AHK | 2 years ago |
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by Rhinomed (ASX:RNO)... |
Stockhead | AHK | 2 years ago |
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin
It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals... |
Stockhead | AHK | 2 years ago |
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed
Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U... |
Stockhead | AHK | 2 years ago |
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact
Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return... |
Stockhead | AHK | 3 years ago |
Ark runs aground at Pine Creek
SYDNEY-based junior Ark Mines, a self-described near-term gold producer since 2013, was placed into administration by its biggest debtholder ... |
Mining News | AHK | 4 years ago |